DFINE Receives CE Mark for STAR Tumor Ablation System

DFINE, a spine device company, has received the CE Mark approval for the STAR Tumor Ablation System for treating painful metastatic spinal tumors.

Advertisement

The company plans to launch the STAR System in Europe next week. The system received the FDA 510(k) clearance in 2010. The system was developed for physicians to target where the device’s energy is delivered to heat and destroy the tumor.

 

More Articles on Spine Devices:
Invibio Biomaterial Solutions Launches Enhanced PEEK-OPTIMA HA Polymer
Titan Spine Debuts Study Supporting Device Surface Technology
SI-BONE Reaches 25k Implantation Milestone for iFuse Device

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.